UPDATE 2-GSK's long acting HIV injection gets boost from study By: Reuters: Company News August 22, 2019 at 06:19 AM EDT * GSK up against competition from Gilead's 3-drug combo (Releads, adds background on rivalry with Gilead) Read More >> Related Stocks: Gilead Sciences Gsk Plc ADR Johnson & Johnson Pfizer